Matthew S. Abbott - 01 Aug 2024 Form 4 Insider Report for Chemours Co (CC)

Reporting relationship: SVP, Chief Ent. Transf. Ofc.
Issuer ticker: CC
Reported as of: 01 Aug 2024
Net transaction value: -$10,559
SEC form: 4
Accepted by SEC: 05 Aug 2024, 16:46:52 UTC
Prior SEC filing: 10 May 2024
Next SEC filing: 19 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Perez Lengel, Attorney-in-Fact

Key filing fact

Matthew S. Abbott filed Form 4 for Chemours Co (CC) on 05 Aug 2024.

Key facts

This page summarizes Matthew S. Abbott's Form 4 filing for Chemours Co (CC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2024, 16:46.

Change

Previous filing in this sequence was filed on 10 May 2024.
Current net transaction value: -$10,559.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Tax liability

Transaction value: $10,559
Shares: -453
Change %: -0.98%
Price: $23.31
Shares after: 45,837
Date: 01 Aug 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

Footnote F2

Includes directly owned shares, restricted stock units and dividend equivalent units.